Orgovyx 120 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FFPJR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,157
Award facts
- Contract value 100% obligated
- $4,156.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for supply of Orgovyx 120 mg tablets (30-count units) on August 13, 2025, with completion targeted for September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. Orgovyx is a gonadotropin-releasing hormone receptor agonist used in the treatment of advanced prostate cancer, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of specialized pharmaceutical products to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime contract extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen Drug Corp supplies a broad range of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare programs. The company's position as a prime vendor reflects its capability to meet federal procurement requirements and support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms designed to ensure reliable pharmaceutical supply chains for military readiness and personnel healthcare.
Quick answers
Who was awarded contract SPE2DB25FFPJR?
SPE2DB25FFPJR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FFPJR worth?
The government has obligated $4,157 on SPE2DB25FFPJR.
Is contract SPE2DB25FFPJR an order under another contract?
Yes. SPE2DB25FFPJR is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFPJR competed?
The extent of competition for SPE2DB25FFPJR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award